StockNews.com initiated coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a research note issued to investors on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the stock. UBS Group dropped their price target on shares of NanoString […]